CA2243657A1 - Composition pour le traitement de la dysfonction erectile - Google Patents

Composition pour le traitement de la dysfonction erectile Download PDF

Info

Publication number
CA2243657A1
CA2243657A1 CA 2243657 CA2243657A CA2243657A1 CA 2243657 A1 CA2243657 A1 CA 2243657A1 CA 2243657 CA2243657 CA 2243657 CA 2243657 A CA2243657 A CA 2243657A CA 2243657 A1 CA2243657 A1 CA 2243657A1
Authority
CA
Canada
Prior art keywords
carrier
treatment
erectile dysfunction
pluronic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2243657
Other languages
English (en)
Other versions
CA2243657C (fr
Inventor
John Di Genova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3439755 CANADA Inc
Original Assignee
3439755 CANADA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3439755 CANADA Inc filed Critical 3439755 CANADA Inc
Priority to CA002243657A priority Critical patent/CA2243657C/fr
Publication of CA2243657A1 publication Critical patent/CA2243657A1/fr
Application granted granted Critical
Publication of CA2243657C publication Critical patent/CA2243657C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
CA002243657A 1998-07-21 1998-07-21 Composition pour le traitement de la dysfonction erectile Expired - Lifetime CA2243657C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002243657A CA2243657C (fr) 1998-07-21 1998-07-21 Composition pour le traitement de la dysfonction erectile

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002243657A CA2243657C (fr) 1998-07-21 1998-07-21 Composition pour le traitement de la dysfonction erectile

Publications (2)

Publication Number Publication Date
CA2243657A1 true CA2243657A1 (fr) 2000-01-21
CA2243657C CA2243657C (fr) 2003-03-25

Family

ID=4162675

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002243657A Expired - Lifetime CA2243657C (fr) 1998-07-21 1998-07-21 Composition pour le traitement de la dysfonction erectile

Country Status (1)

Country Link
CA (1) CA2243657C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3266458A1 (fr) * 2016-07-05 2018-01-10 Fagron B.V. Procédé et composition et kit pour traiter un dysfonctionnement érectile

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3266458A1 (fr) * 2016-07-05 2018-01-10 Fagron B.V. Procédé et composition et kit pour traiter un dysfonctionnement érectile

Also Published As

Publication number Publication date
CA2243657C (fr) 2003-03-25

Similar Documents

Publication Publication Date Title
JPS643193A (en) Cell and tissue reparative agent
CA2310207A1 (fr) Compositions topiques de zinc et methodes d'utilisation
CA2366702A1 (fr) Compositions et procedes d'administration amelioree d'agents therapeutiques hydrophobes ionisables
AU3694901A (en) A parasiticidal formulation and a method of making this formulation
IL114447A0 (en) Multiple unit pharmaceutical preparation
CA2274074A1 (fr) Nouveaux composes a effet analgesique
EA200000629A1 (ru) Стабилизированные растворы терипаратида
CA2411754A1 (fr) Acide 4-¬(4-chloro-2-hydroxybenzoyl)amino|butanoique et compositions d'administration d'agents actifs
CA2339765A1 (fr) Composes et compositions pour l'administration de principes actifs
IL143156A (en) Therapeutic anti-fungal nail preparation
WO2001032596A8 (fr) Composes d'acide carboxylique phenoxy et compositions utilisees afin de diffuser des agents actifs
EP1702597A3 (fr) Apport de médicaments de préparations à changement de phase
AR007715A1 (es) Formulacion acuosa estable de un peptido, un metodo para preparar la misma y su uso para tratamiento
CA2468916A1 (fr) Formulations pharmaceutiques renfermant un derive du platine
CA2185119A1 (fr) Forme galenique pour l'administration d'un medicament dans une formulation liquide
WO2002019999A3 (fr) Compositions et methodes de traitement de dysfonctionnements sexuels
GR3030528T3 (en) Viscoelastic compositions of fluorinated organic compounds
WO2002019969A3 (fr) Acide (5-(2-hydroxy-4-chlorobenzoyl) aminovalerique et ses sels, compositions contenant l'acide et ses sels pour acheminer des agents actifs
CA2360220A1 (fr) Composes a base d'oxadiazole et compositions destinees a l'apport d'agents actifs
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
WO2002030467A3 (fr) Composition destinee a soigner des plaies, renfermant un compose actif du point de vue therapeutique, du miel notamment
CA2251966A1 (fr) Administration transdermique de dextromethorphane servant d'agent antitussif
WO2002000166A3 (fr) Nouveaux composes utiles comme agents antibacteriens
CA2417935A1 (fr) Medicament anti-inflammatoire

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180723

MKEX Expiry

Effective date: 20180723